Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer

Pawel Karpinski, Michael Walter, Elzbieta Szmida, David Ramsey, Blazej Misiak, Joanna Kozlowska, Marek Bebenek, Zygmunt Grzebieniak, Nikolaus Blin, Lukasz Laczmanski and Maria M. Sasiadek
Pawel Karpinski
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Walter
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elzbieta Szmida
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Ramsey
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blazej Misiak
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Kozlowska
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marek Bebenek
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zygmunt Grzebieniak
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaus Blin
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukasz Laczmanski
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria M. Sasiadek
Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-12-0157 Published February 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2012 to January 2021

AbstractFull-text HTMLPDF
Total33051193879

Cited By

Article Information

Volume 22, Issue 2, pp. 201-208

DOI 
https://doi.org/10.1158/1055-9965.EPI-12-0157
PubMed 
23175427

Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Received February 8, 2012
  • Revision received October 10, 2012
  • Accepted October 17, 2012
  • Published first November 21, 2012.

Article Versions

  • Previous version (November 21, 2012 - 08:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2012 American Association for Cancer Research.

Author Information

  1. Pawel Karpinski1,
  2. Michael Walter6,
  3. Elzbieta Szmida1,
  4. David Ramsey7,
  5. Blazej Misiak1,
  6. Joanna Kozlowska1,
  7. Marek Bebenek4,
  8. Zygmunt Grzebieniak3,
  9. Nikolaus Blin1,5,
  10. Lukasz Laczmanski2, and
  11. Maria M. Sasiadek1
  1. Authors' Affiliations: Departments of 1Genetics and 2Endocrinology and Diabetology; 3Second Department of General and Oncological Surgery, Wroclaw Medical University, Poland; 4First Department of Surgical Oncology, Lower Silesian Oncology Center, Wroclaw, Poland; Divisions of 5Molecular Genetics and 6Medical Genetics, Institute of Human Genetics, University of Tuebingen, Tuebingen, Germany; and 7Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
  1. Corresponding Author:
    Pawel Karpinski, Department of Genetics, Wroclaw Medical University, ul. Marcinkowskiego 1, 50-368 Wroclaw, Poland. Phone: 48-71-7841256; Fax: 48-71-7840063; E-mail: polemiraza{at}poczta.fm
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (2)
February 2013
Volume 22, Issue 2
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer
Pawel Karpinski, Michael Walter, Elzbieta Szmida, David Ramsey, Blazej Misiak, Joanna Kozlowska, Marek Bebenek, Zygmunt Grzebieniak, Nikolaus Blin, Lukasz Laczmanski and Maria M. Sasiadek
Cancer Epidemiol Biomarkers Prev February 1 2013 (22) (2) 201-208; DOI: 10.1158/1055-9965.EPI-12-0157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer
Pawel Karpinski, Michael Walter, Elzbieta Szmida, David Ramsey, Blazej Misiak, Joanna Kozlowska, Marek Bebenek, Zygmunt Grzebieniak, Nikolaus Blin, Lukasz Laczmanski and Maria M. Sasiadek
Cancer Epidemiol Biomarkers Prev February 1 2013 (22) (2) 201-208; DOI: 10.1158/1055-9965.EPI-12-0157
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Urinary Melatonin in Relation to Breast Cancer Risk
  • Endometrial Cancer and Ovarian Cancer Cross-Cancer GWAS
  • Risk Factors of Subsequent CNS Tumor after Pediatric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement